EP Patent

EP4356904A1 — A capsule comprising lansoprazole

Assigned to Sanovel Ilac Sanayi ve Ticaret AS · Expires 2024-04-24 · 2y expired

What this patent protects

The present invention relates to pharmaceutical composition in the form of capsule having enteric coating microtablets comprising lansoprazole wherein microtablets comprising maize starch as a diluent and one more diluent. The capsule is obtained by a process which is simple, rap…

USPTO Abstract

The present invention relates to pharmaceutical composition in the form of capsule having enteric coating microtablets comprising lansoprazole wherein microtablets comprising maize starch as a diluent and one more diluent. The capsule is obtained by a process which is simple, rapid, cost effective, time-saving and industrially convenient process.

Drugs covered by this patent

Patent Metadata

Patent number
EP4356904A1
Jurisdiction
EP
Classification
—
Expires
2024-04-24
Drug substance claim
No
Drug product claim
No
Assignee
Sanovel Ilac Sanayi ve Ticaret AS
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.